...
首页> 外文期刊>Der Pharmacia Lettre >Q-Absorbance and Multicomponent UV - Spectrophotometric Methods for Simultaneous Estimation of Rosuvastatin calcium and Fenofibrate in Pharmaceutical Formulation
【24h】

Q-Absorbance and Multicomponent UV - Spectrophotometric Methods for Simultaneous Estimation of Rosuvastatin calcium and Fenofibrate in Pharmaceutical Formulation

机译:Q吸收法和多组分紫外分光光度法同时估计药物制剂中瑞舒伐他汀钙和非诺贝特的含量

获取原文
           

摘要

Two simple UV-Spectrophotometric methods have been developed for simultaneous determination of Rosuvastatin calcium and Fenofibrate in pharmaceutical formulation. Methanol AR grade was used as solvent. In Method-I (Qabsorbance absorbance ratio) involves formation of Q-absorbance equation at two wavelengths i.e. 255.99 nm (isoabsorptive point) and 286 nm (λ max of Fenofibrate). While, in Method-II (Multicomponent Mode of Analysis) involves the measurement of absorbance at two wavelengths i.e. 243 nm, λ max of Rosuvastatin calcium and 286 nm, λ max of Fenofibrate. In both methods, Rosuvastatin calcium and Fenofibrate followed same linearity range at the concentration of 03 - 18 μg/ml at their respective λ max. Both these methods were found to be accurate, precise and rugged as indicated by low values of % RSD. Both these methods were also found to be rapid and economical can successfully be applied for the routine analysis of bulk and combined tablet dosage form.
机译:已经开发了两种简单的紫外分光光度法,用于同时测定药物制剂中的瑞舒伐他汀钙和非诺贝特。甲醇AR级用作溶剂。在方法-I中(吸光度吸光度比)涉及在两个波长即255.99nm(等吸收点)和286nm(非诺贝特的λmax)处形成Q吸光度方程。而在方法II(多组分分析)中,涉及在两个波长即rosuvastatin钙的243 nm,非诺贝特的λmax和286 nm的吸光度的测量。在这两种方法中,瑞舒伐他汀钙和非诺贝特在各自的λmax下,浓度在03-18μg/ ml时都遵循相同的线性范围。如%RSD的低值所示,发现这两种方法都是准确,精确和坚固的。还发现这两种方法都是快速且经济的,可成功地用于散装和组合片剂剂型的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号